Jacobs is an expert on a poxvirus called vaccinia. He has genetically engineered vaccinia as a vehicle against infectious agents, bioterrorism threats, cancer and other viruses, including HIV.

Hogue is a virologist who studies how coronaviruses, a large family of RNA viruses, that includes severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), assemble and cause disease.

Yixin Shi’s research is focused on molecular biology, bacteriology and biochemistry. Shi analyzes the virulent elements necessary for bacterial survival in host environments.

Lake is a cellular and molecular immunologist who is working on biologic inhibitors of tumor cell metastasis. He is also developing a new test for Valley Fever that provides a diagnosis for patients with acute disease.

Dr. Nickerson studies the effects of biomechanical forces on microbial and human cells on Earth and in space, how this response is related to normal homeostasis or disease, and translation to biomedical/biotech applications.

Dr. Liu investigates clinical and molecular signatures of human diseases, and develops novel computational methods to discover biomarkers for early diagnosis and accurate prediction of therapeutic responses for individuals.

Bean applies bioanalytical chemistry methods to characterize microbial, human, animal, plant, and soil metabolomes to identify biomarkers of health and disease.

Emily is using comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GC×GC-TOFMS) to investigate volatile biomarkers for diagnosing disease. 

Varsani is a molecular virologist who works across ecosystems from plants to animals and from the tropics to polar regions.

Dr. Kingsbury is the Executive Director of the Center for Health Pathways in ASU Health, and a Teaching Professor in the John Shufeldt School of Medicine and Medical Engineering.